Linagliptin 2.5mg + Dapagliflozin 10mg Tablets – Laglin DP 5/10 Tablets

Laglin DP 5/10 Tablets – Empowering Glycemic Control with Linagliptin & Dapagliflozin.

Laglin DP 5/10 Tablets – The composition of linagliptin & dapagliflozin tablets is used to treat type-2 diabetes mellitus and which contains Dapagliflozin (sodium-glucose cotransporter-2 inhibitors) and Linagliptin (dipeptidyl peptidase-4 inhibitor). It works by reducing the sugar production by liver cells and delays sugar absorption from the intestines. Thus, Linagliptin+dapagliflozin helps control blood sugar levels.

Key Benefits of Linagliptin 2.5mg + Dapagliflozin 10mg – Laglin DP 5/10
Dual Action for Comprehensive Glycemic Control: Linagliptin enhances insulin secretion and reduces glucose production in the liver, while Dapagliflozin promotes glucose excretion via the kidneys. Together, they provide a comprehensive approach to managing blood sugar in type 2 diabetes.
No Risk of Hypoglycemia (When Used Alone): This combination therapy generally has a low risk of hypoglycemia (low blood sugar) when used alone, providing patients with a safer and more comfortable treatment option compared to other glucose-lowering therapies that may cause hypoglycemia.
Once-Daily Dosing: The combination of Linagliptin and Dapagliflozin offers once-daily dosing, making it easier for patients to adhere to their treatment regimen and improve long-term compliance.

Recommended By Specialists:
Diabetologists: Specialized in diabetes care, treatment options haven’t provided optimal control or for patients with comorbid conditions like cardiovascular disease or chronic kidney disease.
Endocrinologists: Primary prescribers for type 2 diabetes treatment in which the combination is mainly recommended for patients who need dual therapy to improve glycemic control, particularly when monotherapy with a single drug (like metformin or a DPP-4 inhibitor) is insufficient.
General Physicians: For managing type 2 diabetes in patients who require combination therapy, especially when additional control of blood sugar levels and cardiovascular protection is necessary.

INDICATIONS:
Type 2 Diabetes Mellitus (T2DM)
Cardiovascular Risk Reduction in Type 2 Diabetes
Chronic Kidney Disease (CKD) in Type 2 Diabetes